News and Press Releases

Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows

Collaboration aims to equip users with complete NGS solution from sample to answer 12 November 2025 -- Colorado and Indiana, US -- Danaher companies Integrated DNA Technologies (IDT), a global leader in...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 12, 2025

Amersham Place Little Chalfonts Amersham, HP7 9NA

Sanner achieves EcoVadis Gold status

Bensheim/Germany, November 12, 2025 – Sanner, a leading global manufacturer of healthcare packaging solutions and a contract development and manufacturing organization (CDMO) for medtech products, has achieved the EcoVadis Gold...

Category:
Posted: November 12, 2025

Schillerstrasse 76 64625 Bensheim

Acuitas Therapeutics to Showcase LNP Delivery Platform at Four Prestigious Conferences in November 2025

29 October 2025 -- British Columbia, Canada -- Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems, today announced its participation in four upcoming conferences in November 2025....

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 11, 2025

6190 Agronomy Road, Suite 205. Vancouver, BC V6T 1Z3

Dr William G Kaelin Jr joins IQVIA Board of Directors

North Carolina, US — IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr William G Kaelin Jr to its board...

Category:
Posted: November 11, 2025

EpiCypher Launches Fiber-seq Kit to Democratize Single-Molecule Chromatin Mapping

11 November 2025 -- North Carolina, US -- EpiCypher, a leader in chromatin biology and epigenetics, today announced the launch of its CUTANA Fiber-seq Kit and the exclusive licensing of...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 11, 2025

uMotif Harnesses AI to Deliver Faster, Higher-Quality Clinical Trials with MotifAI Assistant

Boston, US, and London, UK – November 3, 2025 –  uMotif – one of the clinical technology market’s fastest-growing companies – today announced a multi-phase deployment of MotifAI Assistant, its AI-driven automation, across...

Category:
Posted: November 11, 2025

2th Floor, WeWork, 10 York Road, London, SE1 7ND, United Kingdom

Commit Biologics achieves proof-of-concept for novel Complement Engager platform in non-human primates

Novel approach harnessing the power of the complement system to drive potent cell depletion Single-dose study shows rapid and sustained immune cell depletion in blood and tissues with a very...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 11, 2025

Universitetsbyen 83 8000 Aarhus C, Denmark

New collaborative strategy platform launches to empower biopharma teams to reach peak sales faster and with greater confidence

11 November 2025 -- London, UK -- In a drug development landscape defined by shifting policies, geopolitical uncertainty, and increasing competitive pressure, a new collaborative strategy platform, Nmblr, has launched to empower...

Category: Biotechnology, Drug Discovery, Logistics, Other, Pharmaceutical
Posted: November 11, 2025

Inside information made public: Nanoform Granted European Commercial cGMP Manufacturing License

Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, today announced that it has received a Commercial cGMP Manufacturing License from FIMEA (Finnish Medicines Agency) for the production...

Category:
Posted: November 11, 2025

Cultivator II, Viikinkaari 4 FI-00790 Helsinki, Finland

Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells

Cambridge, UK, 11 November 2025: Shift Bioscience (Shift), a biotechnology company uncovering the biology of cell rejuvenation to end the morbidity and mortality of aging, today announced the release of...

Category:
Posted: November 11, 2025

Shift Bioscience Ltd The Gurdon Institute Tennis Court Road Cambridge CB2 1QN United Kingdom

Synthego Launches High-Performance Molecular Reagents for Clinical and Molecular Diagnostics

10 November 2025 -- California, US -- Synthego, a leading provider of CRISPR solutions, has announced a strategic expansion of its product offerings with the launch of a new portfolio of...

Category: Biotechnology, Other, Pharmaceutical
Posted: November 10, 2025

3696 Haven Ave Suite A, Redwood City, CA 94063

ACG wins Red Dot Design Award for Personalised Medicine Concept

ACG, the world’s most integrated provider of solid-dosage solutions, is proud to announce that its Personalised Medicine Concept (PMC) has been awarded the prestigious Red Dot Award for high design...

Category:
Posted: November 6, 2025

D Bhabrekar Nagar Road Mumbai, Maharashtra 400067, IN

Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma

Evidence of clinical activity observed in Cohort 8, including stringent complete remission in two patients from Cohort 8 HDP-101 continues to demonstrate a favorable safety profile with no dose-limiting toxicities...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 6, 2025

Gregor-Mendel-Straße 22 68526 Ladenburg Deutschland

H&T Presspart acquires majority stake in Plas-Tech Engineering

Düsseldorf, Germany, 4th November 2025 — H&T Presspart, a division of the Heitkamp & Thumann Group, has reached agreement to acquire a majority stake in Plas-Tech Engineering, a privately-owned medical device...

Category:
Posted: November 5, 2025

Presspart Manufacturing Ltd. Whitebirk Industrial Estate Blackburn, Lancashire BB1 5RF, England

Valneva Reports Positive Results for Phase 1 Trial of Second-Generation Zika Vaccine Candidate

Immune response successfully improved with second generation vaccine candidate4 November 2025 -- Saint-Herblain, France -- Valneva SE, a specialty vaccine company, today announced positive results of its Phase 1 clinical...

Category: BioManufacturing, Biotechnology, Clinical Trials, Drug Delivery, Other, Pharmaceutical
Posted: November 4, 2025

6 rue Alain Bombard, 44800 Saint-Herblain, France